IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

264.53 0.74 +0.28%
Market cap
$43.7B
P/E
31.8×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a

IQVIA Holdings Inc. (IQV) Total debt

Alert me on Total debt

IQVIA Holdings Inc.'s total debt at the end of fiscal 2025 was $15.7B, up 12.5% from $14.0B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $16.1B. Over the past ten years it has ranged from $2.5B (fiscal 2015) to $15.7B (fiscal 2025) — the current reading is the highest in ten years. IQVIA Holdings Inc. ranks 3rd of 46 Diagnostics & Research companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $15.7B 12.45%
FY2024 $14.0B 2.27%
FY2023 $13.7B 7.26%
FY2022 $12.7B 5.13%
FY2021 $12.1B (3.26%)
FY2020 $12.5B 7.63%
FY2019 $11.6B 5.80%
FY2018 $11.0B 7.65%
FY2017 $10.2B 42.01%
FY2016 $7.2B 191.73%

Quarterly newest first

Period Total debt Change
Sep 2026 $16.1B 0.43%
Jun 2026 $16.0B 1.05%
Mar 2026 $15.8B 0.69%
Dec 2025 $15.7B 5.13%
43 more quarters

Against its own ten years

Low $2.5B High $15.7B
Ten-year median $12.1B
Current reading's percentile 100

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on IQV